Press Releases | Health & Wellness Today New York

Explore more publications!

Press Releases

Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M

January 23, 2026

Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M

GlobeNewswire, Inc.

January 23, 2026

NOTICE TO EMERSON EQUITY CUSTOMERS WHO PURCHASED INSPIRED HEALTHCARE CAPITAL INVESTMENTS

EIN Presswire

January 23, 2026

NOTICE TO CUSTOMERS OF ROGER BOWLIN, NATHANIEL HIGGINS & AURORA SECURITIES WHO BOUGHT INSPIRED HEALTHCARE CAPITAL

EIN Presswire

January 23, 2026

Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc. Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire, Inc.

AGL INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health

January 23, 2026

AGL INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health

GlobeNewswire, Inc.

January 23, 2026

AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026

GlobeNewswire, Inc.

Queens New York Medical Malpractice Lawyer: Understanding Medical Errors in Queens New York: Legal Rights, Case Results, and Patient Protection

January 22, 2026

Queens New York Medical Malpractice Lawyer: Understanding Medical Errors in Queens New York: Legal Rights, Case Results, and Patient Protection

GlobeNewswire, Inc.

HealthIMPACT Announces 2026 Changemaker Award Winners Honoring Healthcare’s Architects and Builders of the Future

January 22, 2026

HealthIMPACT Announces 2026 Changemaker Award Winners Honoring Healthcare’s Architects and Builders of the Future

EIN Presswire

Synevra UltraLift Ingredients Investigated: 2026 Consumer Analysis Examines Peptide Serum Formula and Dual-Action Skincare System Disclosures

January 23, 2026

Synevra UltraLift Ingredients Investigated: 2026 Consumer Analysis Examines Peptide Serum Formula and Dual-Action Skincare System Disclosures

GlobeNewswire, Inc.

Levi & Korsinsky Reminds Ardent Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 9, 2026 – ARDT

January 23, 2026

Levi & Korsinsky Reminds Ardent Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 9, 2026 – ARDT

GlobeNewswire, Inc.

agilon health, inc. Class Action: Levi & Korsinsky Reminds agilon health, inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 2, 2026 – AGL

January 23, 2026

agilon health, inc. Class Action: Levi & Korsinsky Reminds agilon health, inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 2, 2026 – AGL

GlobeNewswire, Inc.

January 22, 2026

ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL

GlobeNewswire, Inc.

January 22, 2026

ROSEN, A LONGSTANDING LAW FIRM, Encourages Ardent Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDT

GlobeNewswire, Inc.

January 23, 2026

Tomack Law Exposes ‘Self-Employed’ Myth Amid 2026 NY Labor Crackdown

EIN Presswire

Endometriosis Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

January 22, 2026

Endometriosis Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

GlobeNewswire, Inc.

Dr. Demetra Adams Selected for IAOTP’s Presidential Award

January 23, 2026

Dr. Demetra Adams Selected for IAOTP’s Presidential Award

EIN Presswire

Strongest Brain Health Supplement Criteria for 2026: Nutraville MemoryFuel Formulation Examined

January 22, 2026

Strongest Brain Health Supplement Criteria for 2026: Nutraville MemoryFuel Formulation Examined

GlobeNewswire, Inc.

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026

January 23, 2026

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026

GlobeNewswire, Inc.

Artificial Intelligence in Healthcare Market Shows Explosive Growth at 37.57% CAGR Through 2032

January 22, 2026

Artificial Intelligence in Healthcare Market Shows Explosive Growth at 37.57% CAGR Through 2032

EIN Presswire

January 22, 2026

Bronstein, Gewirtz & Grossman LLC Urges Charming Medical Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire, Inc.